Ionis Pharmaceuticals | IONS - Cash And Equivalent


Ionis Pharmaceuticals reported $2.24B in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Agios Pharmaceuticals USD 92.71M 11.84M Sep/2025
Alnylam Pharmaceuticals USD 1.49B 376.56M Sep/2025
Arrowhead Research USD 88.71M 41.09M Sep/2025
Astellas Pharma JPY 188.37B 8.51B Mar/2025
BioMarin Pharmaceutical USD 1.25B 36.29M Sep/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Exelixis USD 376.3M 211.87M Sep/2025
Halozyme Therapeutics USD 419.66M 357.8M Sep/2025
Ionis Pharmaceuticals USD 2.24B 1.94B Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
Medical Developments International AUD 17.84M 219K Jun/2025
Moderna USD 1.13B 147M Sep/2025
Neuren Pharmaceuticals AUD 5.91M 2.76M Jun/2025
Neurocrine Biosciences USD 340.2M 76.2M Sep/2025
Novartis USD 9.56B 2.9B Sep/2025
OPKO Health USD 411.97M 144.69M Sep/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pfizer USD 1.34B 295M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
PTC Therapeutics USD 672.62M 344.77M Sep/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Regeneron Pharmaceuticals USD 18.87B 16.36B Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Sarepta Therapeutics USD 613.08M 102.48M Sep/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Tilray USD 264.83M 43.16M Jun/2025
Ultragenyx Pharmaceutical USD 202.51M 36.4M Sep/2025
Vertex Pharmaceuticals USD 6.29B 95.8M Sep/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025